
|Articles|August 18, 2022
Daily Medication Pearl: Ganciclovir Injection
Author(s)Saro Arakelians, PharmD
Ganciclovir injection is a nucleoside analogue cytomegalovirus DNA polymerase inhibitor.
Advertisement
Medication Pearl of the Day: Ganciclovir Injection
Indication: Ganciclovir injection is a nucleoside analogue cytomegalovirus (CMV) DNA polymerase inhibitor indicated for the treatment of CMV retinitis in immunocompromised adult patients, including patients with AIDS; prevention of CMV disease in adult transplant recipients at risk for CMV disease.
Insight:
- Dosing: 5 mg/kg every 12 hours.
- Dosage forms: Injection 500 mg ganciclovir in 250 mL (2 mg per mL) solution in a single-dose bag for intravenous use.
- Adverse events: Most common adverse reactions and laboratory abnormalities reported in at least 20% of patients were fever, diarrhea, leukopenia, anemia, catheter related events (including catheter infection and catheter sepsis), and elevated creatinine levels.
- Mechanism of action: Ganciclovir is an antiviral drug with activity against CMV.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Early Oral Antiviral Use Associated With Lower Risk of Post–COVID-19 Condition, Study Finds
2
Retatrutide Delivers Bariatric-Level Weight Loss in Pivotal Phase 3 TRIUMPH-1 Trial
3
Oral GLP-1 Orforglipron Is Approved for Obesity
4
From GLP-1s to Vaccines, APhA 2026 Showcased the Modern Clinical Pharmacist
5




































































































































